| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |